Daily Archives: May 22, 2018


ISPOR Panel Discusses Recommendations and Rationale of “Making Medicines Affordable: A National Imperative”

Session Explores Strategies to Tackle Rising Costs of Prescription Drugs in the United States Without Discouraging Development Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held a session, “‘Making Medicines Affordable: A National Imperative’—Reflections on the National Academies Report” [IP11], this afternoon at ISPOR […]


ISPOR Presents 2018 Awards for Outstanding Achievement in Health Economics and Outcomes Research

Honorees Recognized for Excellence in HEOR Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, recognized honorees of the ISPOR Awards Program at its ISPOR 2018 conference in Baltimore, MD, USA this week. The ISPOR Awards Program is designed to foster and acknowledge excellence and […]


Digital Health—Help or Hype?

Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held its second plenary session, “Digital Health—Help or Hype?,” this morning at ISPOR 2018 in Baltimore, MD, USA. As digital technologies such as smart phones, social media, and wearables have increasingly become available, the potential opportunities […]


Discours de Madame Agnès BUZYN, ministre des Solidarités et de la Santé lors de la Remise des insignes de chevalier de la Légion d’honneur le vendredi 18 mai 2018

seul le prononcé fait foi Mesdames, messieurs les professionnels de santé, Mesdames, Messieurs, Cher Zheng Yi, « Le stratège [chinois], comme l’eau, contourne les obstacles et s’insinue par là où la voie est libre devant lui ; comme l’eau, il ne cesse d’épouser la ligne de moindre résistance et de […]


tofacitinib (Xeljanz)

Generic Name: tofacitinib Brand Name: Xeljanz Manufacturer: Pfizer Canada Inc. Indications: Ulcerative colitis Manufacturer Requested Reimbursement Criteria1: ​Indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response or intolerance to either conventional UC therapy or a biological agent […]


News and press releases: Working together for people with rare and complex diseases

22/05/2018 Working together for people with rare and complex diseases Live broadcast of workshop with European Reference Networks on 29 May The European Medicines Agency (EMA), together with together with RD-ACTION (the European Joint Action for Rare Diseases) and the European Commission’s Directorate General for Health and Food Safety (DG SANTE), is […]